Mindray Has Completed Its Acquisition of a Controlling Stake in DiaSys Diagnostic Systems GmbH

2023-12-01

Mergers & Acquisitions
en-diasys-acquire-kv-pc

On December 1, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (referred to as the “Company” or “Mindray”, SZSE: 300760) announced the completion of its acquisition of a 75% stake in Germany-based DiaSys Diagnostic Systems GmbH (“DiaSys”). Upon completion, DiaSys is now recognized as a majority-owned subsidiary of Mindray.

diasys-acquire-quote1

We are delighted to welcome DiaSys as a member of the Mindray family! The acquisition will allow us to expedite the development of our overseas supply chain platform, access a talented international team, and enhance our In-vitro diagnostics offering. Mindray is committed to offering resources and support to DiaSys while leveraging our extensive experience in global integration to achieve effective synergistic growth for both companies.

 

Wu Hao

President of Mindray

diasys-acquire-quote2

We are thrilled by being now a part of Mindray and being able to enhance the capabilities and expand the global footprint of both parties involved! Our family of companies is ready for an intensive future growth and collaboration. Both companies will support each other to optimize market coverage in the future together.

 

Dr. Günther Gorka

Founder of DiaSys

Upon completion of the transaction, DiaSys will be integrated into Mindray's system. With a unified team, both parties will work closely together to enhance products, facilitate joint development, expand platforms, and execute the DiaSys integration plan orderly and smoothly. This strategic alignment aims to substantially strengthen Mindray's global competitive edge in the In-vitro diagnostics business.

About DiaSys

Established in 1991 and headquartered in Holzheim, Germany, DiaSys has over three decades of experience in the fields of In-vitro diagnostics reagents, calibrators, and controls. As the global pioneer in liquid-stable, ready-to-use biochemical reagents, DiaSys has established a solid reputation among its international customers. The company has built an extensive global supply chain system, with production facilities across Europe, APAC, and Latin America. DiaSys also possesses robust R&D and production capabilities in calibrators and controls, ensuring the delivery of top-quality products to its customers.

For more information, please visit https://www.diasys-diagnostics.com


About Mindray

Mindray is a leading high-tech medical device manufacturer in China, and one of the global leaders in medical innovation. The company’s business covers patient monitoring and life support, In-vitro diagnostics and medical imaging system. Mindray is committed to creating customer value with comprehensive solutions through cutting-edge technological innovation, improving medical conditions, and enhancing efficiency. In October 2018, Mindray was listed on the Shenzhen Stock Exchange's ChiNext board (SZSE: 300760).